BackZealand Pharma A/S. Overview

Zealand Pharma A/S. Total Liabilities

Track Zealand Pharma A/S.'s total liabilities ($1.1B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$1.13B

Peer trimmed avg / median

Loading

Zealand Pharma A/S. Total Liabilities History

Loading

Zealand Pharma A/S. vs. peers: Total Liabilities Comparison

Loading

Zealand Pharma A/S. Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Zealand Pharma A/S. (ZEAL) FAQ

Zealand Pharma A/S. posts a total liabilities of $1.1B as of March 2022. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

Total Liabilities is one piece of Zealand Pharma A/S.'s financial statement story. At $1.1B, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for ZEAL's total liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Zealand Pharma A/S.'s other metric pages and overview cover the third.

Judging Zealand Pharma A/S. against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in total liabilities easier to interpret. Start with $1.1B here, then scan peer and history charts to see if the gap is persistent.